Pediatric Coding Alert

Reader Questions:

Claim Timing Could Keep Away 90670 Pay

Question:We've had trouble being paid for 90670. What diagnosis should we report, and should we follow certain guidelines?Alabama Subscriber Answer:CPT 2010 added 90670 (Pneumococcal conjugate vaccine, 13 valent, for intramuscular use) with a notation of "FDA approval pending." The code went into effect May 25, 2010, so insurers will reject any claims you submitted before that date. Smaller plans and PPO networks can take longer to recognize new vaccines, so prepare to resubmit with documentation of the code's acceptability. In terms of a diagnosis, report V03.82 (Need for prophylactic vaccination and inoculation against bacterial diseases; Streptococcus pneumoniae [pneumococcus]).
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pediatric Coding Alert

View All